Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Aerts

Showing results (91-100 of 123) with videos related to

Pageof 13
Sort By:
Cancers|October 23, 2020
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory CancersSarah Jannier, Véronique Kemmel, Consuelo Sebastia Sancho, et al.
Cancer Epidemiology|November 8, 2024
Life years lost by childhood cancer treatment and health related late effects among childhood cancer survivorsThibaud Charrier, Nadia Haddy, Brice Fresneau, et al.
Expert Review of Anticancer Therapy|July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysisLauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.
European Heart Journal|September 23, 2025
Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control studyNaïla Aba, Gwénaël Le Teuff, Brice Fresneau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART TrialSusanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
The Lancet. Oncology|August 20, 2021
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 studyNathalie Gaspar, Rajkumar Venkatramani, Stefanie Hecker-Nolting, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Molecular diagnosis of retinoblastoma by circulating tumor DNA analysisIrene Jiménez, Éléonore Frouin, Mathieu Chicard, et al.
Nature Communications|April 8, 2024
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastomaAmélie Roehrig, Theo Z Hirsch, Aurore Pire, et al.
Pageof 13

Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Cancers|October 23, 2020
SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory CancersSarah Jannier, Véronique Kemmel, Consuelo Sebastia Sancho, et al.
Cancer Epidemiology|November 8, 2024
Life years lost by childhood cancer treatment and health related late effects among childhood cancer survivorsThibaud Charrier, Nadia Haddy, Brice Fresneau, et al.
Expert Review of Anticancer Therapy|July 12, 2023
Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysisLauriane Lemelle, Delphine Guillemot, Anne-Laure Hermann, et al.
European Heart Journal|September 23, 2025
Transcriptomic biomarkers related to cardiac disease in childhood cancer survivors: a case-control studyNaïla Aba, Gwénaël Le Teuff, Brice Fresneau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory <i>BRAF</i> V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.
Hormone Research in Paediatrics|November 8, 2014
Water and electrolyte disorders at long-term post-treatment follow-up in paediatric patients with suprasellar tumours include unexpected persistent cerebral salt-wasting syndromeLaura González Briceño, Jacques Grill, Franck Bourdeaut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART TrialSusanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
The Lancet. Oncology|August 20, 2021
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 studyNathalie Gaspar, Rajkumar Venkatramani, Stefanie Hecker-Nolting, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2021
Molecular diagnosis of retinoblastoma by circulating tumor DNA analysisIrene Jiménez, Éléonore Frouin, Mathieu Chicard, et al.
Nature Communications|April 8, 2024
Single-cell multiomics reveals the interplay of clonal evolution and cellular plasticity in hepatoblastomaAmélie Roehrig, Theo Z Hirsch, Aurore Pire, et al.
Pageof 13